Unequal CAB count means US delay on MRA (mutual recognition agreement):
This article was originally published in Clinica
Following a long silence on the mutual recognition agreement(MRA) between the EU and the US, which most observers had expected would be officially adopted by now, it now seems that more observed audits will need to take place in the US before full implementation can take place. Indications are that the US now wants to ensure that it has as many conformity assessment bodies as the EU (currently it has three, compared to six in the EU). The speed at which the CABs can be recognised as ready for listing will depend on industry's willingness to invite potential conformity assessment bodies based in the US to take part in observed audits. In the past, companies were slow to put themselves forward and it is unclear what the situation is now.